{"gene":"NDRG2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2014,"finding":"NDRG2 is a PTEN-binding protein that recruits protein phosphatase 2A (PP2A) to PTEN, thereby promoting dephosphorylation of PTEN at the Ser380/Thr382/Thr383 cluster within the C-terminal tail; loss of NDRG2 leads to enhanced PTEN phosphorylation at this cluster, inactivating PTEN and constitutively activating the PI3K-AKT pathway.","method":"Co-immunoprecipitation, binding assays, phosphorylation analysis, cell-based overexpression/knockdown, Ndrg2-knockout mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP establishing the NDRG2-PTEN-PP2A complex, multiple orthogonal methods (binding, phosphorylation assays, KO mice), replicated in subsequent papers (PMID:26269411)","pmids":["24569712"],"is_preprint":false},{"year":2015,"finding":"NDRG2 also recruits PP2A to NF-κB-inducing kinase (NIK), promoting NIK dephosphorylation and thereby suppressing the non-canonical NF-κB pathway, in addition to its role in suppressing PI3K/AKT signaling via PTEN dephosphorylation.","method":"Forced expression of NDRG2 in ATL cells, immunoprecipitation, phosphorylation assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, Co-IP and phosphorylation data, single study without independent replication","pmids":["26269411"],"is_preprint":false},{"year":2004,"finding":"Akt directly phosphorylates NDRG2 at Thr-348 in response to insulin, while PKCθ phosphorylates NDRG2 at Ser-332; PKCθ overexpression reduces insulin-stimulated Thr-348 phosphorylation without reducing Akt activation, suggesting cross-talk at the substrate level.","method":"In vitro kinase assay, site-directed mutagenesis, [32P]-orthophosphate labeling, phospho-Akt-substrate antibody, co-overexpression in C2C12 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase reconstitution with mutagenesis confirming specific phosphorylation sites, supported by cell-based validation with multiple methods","pmids":["14985363"],"is_preprint":false},{"year":2016,"finding":"DAPK1 directly interacts with NDRG2 and phosphorylates it at Ser350 in vitro and in vivo; DAPK1-mediated phosphorylation of NDRG2-Ser350 promotes caspase-dependent neuronal cell death, and DAPK1 inhibition abolishes NDRG2-Ser350 phosphorylation and reduces neuronal death in primary neurons and mouse brain.","method":"Phospho-peptide library screening, in vitro kinase assay, Co-IP, cell-based overexpression and shRNA knockdown, primary neuron experiments, Tg2576 mouse model","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Strong — substrate identified by peptide library screen, confirmed by in vitro phosphorylation with mutagenesis, validated in multiple cell models and in vivo","pmids":["28141794"],"is_preprint":false},{"year":2006,"finding":"c-Myc represses NDRG2 transcription through interaction with the NDRG2 core promoter via Miz-1 and recruitment of histone deacetylases; Miz-1 association is required for c-Myc-mediated NDRG2 repression.","method":"Reporter assay, chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), ectopic c-Myc expression, Miz-1 co-expression/knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP and in vitro/in vivo promoter binding with mutagenesis, multiple orthogonal methods, mechanistic dissection of Miz-1 requirement","pmids":["17050536"],"is_preprint":false},{"year":2022,"finding":"Cytoplasmic NDRG2 in astrocytes binds to the protein phosphatase PPM1A and restricts dephosphorylation of Smad2/3; after subarachnoid hemorrhage, this NDRG2-PPM1A interaction reduces Smad2/3 dephosphorylation, sustaining MMP-9 transcription and blood-brain barrier disruption. A blocking peptide (TAT-QFNP12) that disrupts the NDRG2-PPM1A interaction attenuates MMP-9 production and BBB damage.","method":"Co-immunoprecipitation, Ndrg2 astrocyte-specific knockout mice, phosphorylation analysis of Smad2/3, peptide competition, in vivo SAH model","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, cell-specific KO model, functional peptide rescue, mechanistic pathway validated with multiple orthogonal approaches","pmids":["36179025"],"is_preprint":false},{"year":2007,"finding":"NDRG2 stimulates amiloride-sensitive ENaC currents by increasing ENaC surface expression in Xenopus oocytes and Fisher rat thyroid cells; siRNA knockdown of NDRG2 reduces ENaC-mediated short-circuit current, and the stimulatory effect is at least partially additive to Sgk1.","method":"Xenopus oocyte electrophysiology, chemiluminescence surface expression assay, siRNA knockdown in Fisher rat thyroid cells, short-circuit current measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — functional electrophysiology with surface expression quantification, confirmed in two heterologous cell systems with loss-of-function validation","pmids":["17652085"],"is_preprint":false},{"year":2006,"finding":"NDRG2 physically interacts with MSP58 (58-kDa microspherule protein) via the forkhead-associated domain of MSP58; the two proteins co-localize in the nucleus during cell stress, and modulation of NDRG2 levels influences cell cycle progression together with MSP58.","method":"Yeast two-hybrid screening, GST pull-down, co-immunoprecipitation, confocal co-localization","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple binding confirmation methods (yeast two-hybrid, pull-down, Co-IP, co-localization), single lab, functional consequence partially characterized","pmids":["17109818"],"is_preprint":false},{"year":2012,"finding":"NDRG2 interacts with prenylated Rab acceptor-1 (PRA1) as identified by yeast two-hybrid screening; the interaction was confirmed by GST pull-down and immunoprecipitation. NDRG2 and PRA1 co-localize in HCT116 cells and synergistically downregulate TCF promoter activity and GSK3β phosphorylation.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, confocal microscopy, TCF/LEF luciferase reporter assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — binding confirmed by three orthogonal methods plus functional reporter assay, single lab","pmids":["23068607"],"is_preprint":false},{"year":2009,"finding":"NDRG2 expression in colon carcinoma cells reduces c-Jun phosphorylation at Ser63, attenuating AP-1 transcriptional activity and downstream cyclin D1 expression, resulting in G1/S cell cycle arrest; NDRG2 mutants lacking C-terminal phosphorylation sites lose this activity.","method":"Stable cell lines with wild-type and deletion/point mutant NDRG2, Western blotting, luciferase reporter assay, flow cytometry, siRNA rescue","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis identifying C-terminal phosphorylation sites as required, multiple assays, single lab","pmids":["18844221"],"is_preprint":false},{"year":2009,"finding":"NDRG2 expression reduces TCF/LEF transcriptional activity in colon cancer cells and modulates β-catenin stability through regulation of GSK-3β activity; NDRG2 mutants lacking C-terminal phosphorylation sites lose this regulatory activity.","method":"TOPflash TCF/LEF luciferase reporter assay, Western blotting for β-catenin and GSK-3β, site-directed mutagenesis, stable cell transfection","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter and mutagenesis in single lab, mechanistically tied to GSK-3β activity modulation","pmids":["19237607"],"is_preprint":false},{"year":2018,"finding":"NDRG2 induction of colorectal cancer cell differentiation is dependent on repression of E3 ligase Skp2, which stabilizes the CDK inhibitors p21 and p27; NDRG2 suppresses Skp2 by reducing β-catenin nuclear translocation and decreasing β-catenin/TCF occupancy on the Skp2 promoter, potentially through dephosphorylation of GSK-3β. The NH2-terminal domain of NDRG2 is required for Skp2 suppression.","method":"Ndrg2 knockout mice, shRNA knockdown, Western blotting, ChIP, promoter occupancy assay, NDRG2 deletion mutants, alkaline phosphatase (AKP) activity assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mapping combined with KO mouse model and ChIP confirming promoter occupancy, multiple orthogonal methods in single lab plus in vivo validation","pmids":["29343851"],"is_preprint":false},{"year":2015,"finding":"NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression via suppression of β-catenin nuclear translocation, which reduces transcriptional activation of the C-MYC gene; this consequently decreases expression of GLUT1, HK2, PKM2, LDHA, ASCT2, and GLS1.","method":"Metabolite measurement (glucose/lactate/glutamine/glutamate), Western blotting, β-catenin knockdown, c-Myc knockdown, NDRG2 overexpression in colorectal cancer cells","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional metabolic assays combined with mechanistic pathway dissection, single lab with multiple methods","pmids":["26317652"],"is_preprint":false},{"year":2020,"finding":"NDRG2 ablation induces glutamine dependence via Akt-dependent inhibition of Fbw7-mediated c-Myc degradation, which increases c-Myc-driven ASCT2 (glutamine transporter) transcription; NDRG2 promotes Fbw7-dependent c-Myc degradation by inhibiting Akt, and ASCT2 restoration reverses NDRG2's inhibitory effect on EMT and metastasis.","method":"Immunoprecipitation, protein half-life assay, luciferase reporter, ChIP, mRNA-seq, NDRG2-knockout MEF cells, functional invasion/migration assays","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic chain (NDRG2→Akt→Fbw7→c-Myc→ASCT2) validated by IP, ChIP, half-life, and functional rescue in single lab","pmids":["33162818"],"is_preprint":false},{"year":2019,"finding":"NDRG2 promotes astroglial glutamate uptake by interacting with and promoting the function of Na+/K+-ATPase β1 subunit; NDRG2 knockout reduces EAAT-mediated glutamate uptake and increases interstitial glutamate in mouse brain, leading to greater neuronal death upon glutamate challenge.","method":"Ndrg2-knockout mice, Co-IP demonstrating NDRG2-Na+/K+-ATPase β1 interaction, glutamate uptake assay in astrocytes, Na+/K+-ATPase β1 blocking peptide, neuronal death assay, in vivo ischemia model","journal":"Translational stroke research","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse model combined with Co-IP establishing binding partner and functional consequence, peptide competition confirming mechanism, in vitro and in vivo validation","pmids":["31250377"],"is_preprint":false},{"year":2017,"finding":"KLF4 transcriptionally activates NDRG2 by directly binding to the NDRG2 promoter; KLF4-dependent inhibition of colorectal cancer cell proliferation is dependent on NDRG2 expression, as NDRG2 knockdown abrogates the anti-proliferative effect of KLF4.","method":"Chromatin immunoprecipitation, luciferase reporter assay, MTT assay, EdU staining, colony formation, xenograft mouse model, siRNA knockdown","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter confirming direct promoter binding, epistasis validated by rescue experiment, single lab","pmids":["28656310"],"is_preprint":false},{"year":2014,"finding":"Farnesoid X receptor (FXR) directly controls NDRG2 transcription through IR1-type response elements identified in the first introns of the human, mouse and rat NDRG2 genes, as supported by gene reporter assays and chromatin immunoprecipitation.","method":"Gene reporter assay, chromatin immunoprecipitation, FXR ectopic expression, FXR knockout mice, non-steroidal FXR agonist treatment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with FXR binding element identified, validated in FXR KO mice and agonist-treated cells, single lab","pmids":["23056173"],"is_preprint":false},{"year":2008,"finding":"NDRG2 overexpression in liver cancer cells specifically induces active BMP-4 expression; neutralization of BMP-4 in NDRG2-expressing cells restores MMP-9 mRNA expression and migration capacity, demonstrating that NDRG2 suppresses MMP-9 activity and migration through BMP-4 induction.","method":"NDRG2 stable overexpression, BMP-4 neutralizing antibody, recombinant BMP-4 treatment, gelatin zymography for MMP-9 activity, migration and invasion assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by BMP-4 neutralization rescue experiment, multiple functional readouts, single lab","pmids":["19450561"],"is_preprint":false},{"year":2007,"finding":"NDRG2 expression in breast cancer cells increases SOCS1 mRNA and protein expression in a p38 MAPK-dependent manner; this SOCS1 induction inhibits JAK2/STAT3 activation, as p38 MAPK inhibition blocks SOCS1 induction by NDRG2 and rescues STAT3 phosphorylation.","method":"Western blotting for phospho-Akt, p38, JNK, JAK2, STAT3, RT-PCR for SOCS1, p38 inhibitor treatment, stable NDRG2 overexpression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis confirmed by kinase inhibitor rescue, multiple phosphorylation readouts, single lab","pmids":["17888401"],"is_preprint":false},{"year":2011,"finding":"NDRG2 suppresses TGF-β1/Smad3 signaling in hepatic stellate cells by reducing Smad3 transcription and phosphorylation, and increases the MMP2/TIMP2 ratio; adenovirus-mediated NDRG2 overexpression in fibrotic rat livers reduces ECM deposition and improves liver function.","method":"NDRG2 overexpression and knockdown in HSCs, Western blotting for phospho-Smad3, gelatin zymography, adenovirus delivery in dimethylnitrosamine-induced rat fibrosis model","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro signaling combined with in vivo adenoviral overexpression in fibrosis model, single lab","pmids":["22110735"],"is_preprint":false},{"year":2020,"finding":"NDRG2 directly interacts with NF-κB and inhibits nuclear import and DNA binding activity of the NF-κB p65 subunit in astrocytes after OxyHb treatment, reducing glutamate transporter 1 (GLT1) transcription and impairing glutamate uptake in the context of intracerebral hemorrhage.","method":"Ndrg2-knockout mice, Co-IP demonstrating NDRG2-NF-κB interaction, NF-κB nuclear translocation assay, GLT1 promoter analysis, primary astrocyte culture, ICH mouse model","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing direct NDRG2-NF-κB interaction, functional consequence on GLT1 and glutamate uptake validated in KO mice, single lab","pmids":["31843625"],"is_preprint":false},{"year":2020,"finding":"In NDRG2-deficient astrocytes, NDRG2 loss increases NF-κB phosphorylation, activating complement C3 transcription; NDRG2 overexpression inhibits complement C3 via NF-κB suppression, reducing synaptic injury in diabetic mice. C3aR blockade rescued dendritic spine loss consistent with NDRG2/NF-κB/C3/C3aR as a signaling axis.","method":"Ndrg2 knockout and overexpression in vivo, Western blotting, immunofluorescence, electrophysiology, Golgi staining, RNA-seq and proteome sequencing with WGCNA","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-omics combined with in vivo genetic manipulation and pharmacological C3aR blockade, single lab with multiple orthogonal approaches","pmids":["37329577"],"is_preprint":false},{"year":2020,"finding":"NDRG2 enhances FBXO11-mediated ubiquitination and degradation of Snail (a repressor of E-cadherin), thereby maintaining E-cadherin expression and adherens junction integrity in intestinal epithelial cells; intestine-specific Ndrg2 deletion leads to Snail accumulation, E-cadherin loss, and increased intestinal permeability.","method":"Intestine-specific Ndrg2 knockout mice, Co-IP for NDRG2-FBXO11-Snail complex, ubiquitination assay, Western blotting, barrier permeability assay, DSS/TNBS colitis models","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP establishing ternary complex, ubiquitination assay, tissue-specific KO with functional phenotype, multiple disease models","pmids":["33099085"],"is_preprint":false},{"year":2012,"finding":"NDRG2 overexpression in rat liver cells induces cell cycle arrest and apoptosis associated with induction of p53 and p21, increased Bax/Bcl-2 ratio, and inhibition of cyclin E-Cdk2; conversely, p53 upregulates NDRG2 expression in A-498 cells, suggesting a positive feedback loop.","method":"Adenoviral NDRG2 overexpression in BRL cells, flow cytometry, Western blotting for cell cycle regulators and apoptosis markers","journal":"Wound repair and regeneration","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, KO/overexpression with Western blot readouts but no direct binding or epistasis confirmation for p53-NDRG2 relationship","pmids":["20840522"],"is_preprint":false},{"year":2013,"finding":"NDRG2 acts downstream of PI3K/Akt signaling in cardiomyocytes; insulin increases Akt-dependent NDRG2 phosphorylation, and shRNA knockdown of NDRG2 renders cardiomyocytes more susceptible to ischemia/reperfusion injury and blunts insulin's anti-apoptotic cardioprotective effect.","method":"Rat I/R model, lentiviral shRNA NDRG2 knockdown in cardiomyocytes and in vivo, Western blotting for phospho-Akt and phospho-NDRG2, wortmannin/Akt inhibitor pretreatment, infarct size measurement","journal":"Basic research in cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in vitro and in vivo with PI3K/Akt inhibitor epistasis, single lab","pmids":["23463182"],"is_preprint":false},{"year":2010,"finding":"NDRG2 is highly expressed in pancreatic beta cells and acts as an Akt substrate; in beta cells under lipotoxic stress, Akt-mediated NDRG2 phosphorylation is reduced; NDRG2 knockdown attenuates constitutively active Akt-mediated protection against fatty acid-induced apoptosis, placing NDRG2 downstream of Akt in beta cell survival signaling.","method":"Stable overexpression of constitutively active Akt, NDRG2 knockdown in beta-TC3 cells, Western blotting, apoptosis assay","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (active Akt + NDRG2 knockdown rescue) in beta cell model, functional apoptosis readout, single lab","pmids":["20127388"],"is_preprint":false},{"year":2005,"finding":"NDRG2 protein (both S and L isoforms) localizes specifically to cell surface membranes and growth cones in NGF-differentiated PC12 cells, and overexpression of either isoform promotes neurite elongation.","method":"V5-tagged NDRG2 transfection, immunofluorescence/confocal microscopy, real-time qPCR for expression, morphological measurement of neurite length","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by immunofluorescence tied to functional phenotype (neurite elongation), replicated for both isoforms, single lab","pmids":["16039777"],"is_preprint":false},{"year":2011,"finding":"In cultured astrocytes, Ndrg2 gene silencing enhances cell proliferation (BrdU/PCNA incorporation) and reduces F-actin levels and process length, while Ndrg2 overexpression has opposite effects; fractionation and immunocytochemistry show Ndrg2 in cytosol and cell surface membrane fractions.","method":"Adenovirus-mediated Ndrg2 overexpression and siRNA knockdown in astrocytes, BrdU incorporation, PCNA staining, F-actin quantification, subcellular fractionation, MPTP mouse model","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — bidirectional manipulation (overexpression and knockdown) with consistent proliferation and morphology readouts, subcellular fractionation, single lab","pmids":["21672576"],"is_preprint":false},{"year":2017,"finding":"NDRG2 deficiency in Ndrg2-knockout mice leads to markedly increased interstitial glutamate and reduced astroglial glutamate clearance; an NDRG2 peptide rescues astroglial glutamate clearance, reduces excitatory transmission, and rescues ADHD-like hyperactivity in Ndrg2-/- mice.","method":"Ndrg2-knockout mice, microdialysis for interstitial glutamate, electrophysiology for excitatory transmission, astrocyte glutamate uptake assay, NDRG2 peptide treatment, behavioral testing","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse model with multiple functional readouts (glutamate levels, electrophysiology, behavior), peptide rescue confirming mechanism, published in high-impact journal with rigorous controls","pmids":["29058689"],"is_preprint":false},{"year":2021,"finding":"NDRG2 overexpression in breast cancer cells inhibits PD-L1 expression through NF-κB signaling; knockdown of NDRG2 enhances PD-L1 expression and leads to suppression of T cell proliferation in co-culture, while NDRG2 overexpression in 4T1 mouse cells blocks tumor cell-mediated suppression of T cell proliferation.","method":"NDRG2 overexpression and knockdown, Western blotting, RT-qPCR, T cell proliferation co-culture assay, NF-κB pathway analysis","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation with functional T cell co-culture readout, NF-κB mechanistic link, single lab","pmids":["34885221"],"is_preprint":false},{"year":2020,"finding":"NDRG2 suppression in astrocytes attenuates ischemia-induced necroptosis by suppressing RIPK1 expression; Ndrg2-/- mice exhibit accelerated necroptosis after cerebral artery occlusion, and pharmacological inhibition of necroptosis by necrostatin-1 provides neuroprotection after NDRG2 knockdown.","method":"Ndrg2 conditional knockout mice, Western blotting for RIPK1 and necroptosis markers, necrostatin-1 treatment, permanent MCAO model","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with pharmacological epistasis (necrostatin-1 rescue), single lab","pmids":["32945444"],"is_preprint":false},{"year":2022,"finding":"Lactate stabilizes NDRG2 in astrocytes under oxygen-glucose deprivation by inhibiting its ubiquitination; NDRG2 knockdown in astrocytes increases TNFα expression and secretion via c-Jun phosphorylation, indicating that NDRG2 suppresses neuroinflammation by restraining the c-Jun/TNFα axis.","method":"Ubiquitination assay, Western blotting, siRNA knockdown, exogenous lactate treatment, RNA-seq transcriptomics, primary astrocyte culture, MCAO rat model","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay directly showing lactate-mediated stabilization, mechanistic link to c-Jun/TNFα, single lab","pmids":["36572898"],"is_preprint":false},{"year":2012,"finding":"Ndrg2 loss in mice results in vertebral homeotic transformations; at the molecular level, this is accompanied by altered Hoxc8-11 gene transcripts and elevated BMP/Smad signaling in differentiating somites, identifying Ndrg2 as a regulator of vertebral specification after somite segmentation.","method":"Ndrg2-knockout mice, conditional knockout in osteoblasts/chondrocytes, Ndrg2 overexpression in osteoblasts/chondrocytes, in situ hybridization for Hox genes, immunostaining for phospho-Smad","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic models (global KO, cell-type-specific KO and OE) with molecular readouts, single lab","pmids":["22819676"],"is_preprint":false},{"year":2014,"finding":"NDRG2 is predominantly localized to the cytosol of protoplasmic and fibrous astrocytes in mammalian brain, including fine distal processes but not Müller glia; NDRG2 is reduced in reactive astrocytes at a cortical lesion, suggesting its expression is specific to mature, non-reactive astrocytes.","method":"Immunohistochemistry and confocal immunofluorescence with astrocyte markers (GFAP, S100β, aquaporin-4, nestin, NG2) in multiple species (mouse, rat, tree shrew, marmoset, human), cortical lesion model","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — extensive multi-species immunolocalization with co-marker analysis, direct functional implication (reduction in reactive astrocytes), multiple orthogonal markers","pmids":["24816982"],"is_preprint":false},{"year":2011,"finding":"NDRG2 regulates CD24 expression in hepatocellular carcinoma cells; NDRG2 upregulation decreases CD24 expression and reduces cell adhesion, migration and invasion, while NDRG2 downregulation enhances CD24 expression and increases these behaviors.","method":"Adenovirus-mediated NDRG2 overexpression and siRNA knockdown in HCC cells, Western blotting, adhesion/migration/invasion assays, IHC correlation in 50 patient specimens","journal":"BMC cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, functional assays linking NDRG2 to CD24 without direct binding confirmation; mechanism of CD24 regulation unspecified","pmids":["21676268"],"is_preprint":false}],"current_model":"NDRG2 functions primarily as an adaptor/scaffold protein: it recruits PP2A phosphatase to PTEN (dephosphorylating and activating PTEN to suppress PI3K/AKT) and to NIK (suppressing non-canonical NF-κB), interacts with Na+/K+-ATPase β1 in astrocytes to promote EAAT-mediated glutamate uptake, binds PPM1A to regulate Smad2/3 dephosphorylation and MMP-9 transcription, enhances FBXO11-mediated Snail ubiquitination to maintain E-cadherin/adherens junctions, and is itself phosphorylated by Akt (at Thr-348) and PKCθ (at Ser-332) downstream of insulin signaling, and by DAPK1 (at Ser-350) to promote neuronal apoptosis; transcriptionally, c-Myc represses NDRG2 via Miz-1, FXR and KLF4 activate it, and aldosterone induces it as an early mineralocorticoid-specific response gene that enhances ENaC surface expression."},"narrative":{"mechanistic_narrative":"NDRG2 is a cytosolic adaptor/scaffold protein that suppresses proliferative and inflammatory signaling by recruiting protein phosphatases to specific substrates and by controlling protein stability through dedicated E3 ligases [PMID:24569712, PMID:36179025, PMID:33099085]. Its best-defined activity is recruiting PP2A to PTEN, driving dephosphorylation of the PTEN C-terminal Ser380/Thr382/Thr383 cluster to activate PTEN and restrain PI3K-AKT signaling; loss of NDRG2 hyperphosphorylates PTEN and constitutively activates AKT [PMID:24569712]. The same scaffolding logic extends to PP2A recruitment to NIK to dampen non-canonical NF-κB [PMID:26269411], and to PPM1A engagement, where cytoplasmic NDRG2 restricts Smad2/3 dephosphorylation to sustain MMP-9 transcription [PMID:36179025]. NDRG2 also stabilizes adherens junctions by enhancing FBXO11-mediated ubiquitination and degradation of the E-cadherin repressor Snail [PMID:33099085]. Across colorectal cancer models NDRG2 converges on the β-catenin/c-Myc axis, suppressing β-catenin nuclear translocation and TCF/LEF activity to repress Skp2, c-Myc, and downstream glycolytic and glutaminolytic programs, thereby imposing G1/S arrest and a differentiated phenotype [PMID:29343851, PMID:26317652, PMID:33162818]. In the brain, NDRG2 is an astrocyte-enriched protein that interacts with the Na+/K+-ATPase β1 subunit to promote EAAT-mediated glutamate uptake, limiting excitotoxicity and behavioral hyperactivity [PMID:31250377, PMID:29058689]. NDRG2 is itself a phosphorylation hub: AKT phosphorylates it at Thr-348 and PKCθ at Ser-332 downstream of insulin [PMID:14985363], while DAPK1 phosphorylates Ser-350 to promote caspase-dependent neuronal death [PMID:28141794]. Its expression is repressed by c-Myc via Miz-1 and activated by KLF4 and FXR [PMID:17050536, PMID:28656310, PMID:23056173].","teleology":[{"year":2004,"claim":"Established that NDRG2 is a direct kinase substrate integrating insulin signaling, defining the regulatory phosphorylation sites that gate its activity.","evidence":"In vitro kinase assays with site-directed mutagenesis and [32P] labeling in C2C12 cells identifying Akt-Thr348 and PKCθ-Ser332","pmids":["14985363"],"confidence":"High","gaps":["Functional consequence of each phosphosite on NDRG2 scaffold activity not resolved","Did not address downstream effectors of phosphorylated NDRG2"]},{"year":2006,"claim":"Showed how NDRG2 expression itself is controlled, identifying c-Myc/Miz-1 as a transcriptional repressor circuit.","evidence":"Reporter assays, ChIP, and EMSA with ectopic c-Myc and Miz-1 manipulation","pmids":["17050536"],"confidence":"High","gaps":["Reciprocal regulation (NDRG2 repressing c-Myc) not yet connected","HDAC identity at the promoter unspecified"]},{"year":2014,"claim":"Defined the core molecular mechanism of NDRG2 as a phosphatase-recruiting scaffold, explaining its tumor-suppressive link to PI3K-AKT.","evidence":"Reciprocal Co-IP, phosphorylation analysis of the PTEN C-terminal cluster, and Ndrg2-knockout mice","pmids":["24569712"],"confidence":"High","gaps":["Structural basis of the NDRG2-PTEN-PP2A ternary complex unknown","Which PP2A holoenzyme is recruited not specified"]},{"year":2015,"claim":"Generalized the scaffold model by showing NDRG2 also recruits PP2A to NIK to suppress non-canonical NF-κB.","evidence":"Forced NDRG2 expression in ATL cells with immunoprecipitation and phosphorylation assays","pmids":["26269411"],"confidence":"Medium","gaps":["Single study without independent replication","Direct NDRG2-NIK binding versus PP2A bridging not distinguished"]},{"year":2016,"claim":"Revealed a death-promoting arm of NDRG2 regulation, showing DAPK1 phosphorylation converts NDRG2 into a pro-apoptotic neuronal factor.","evidence":"Phospho-peptide library screen, in vitro kinase assay with mutagenesis, and validation in primary neurons and Tg2576 mice","pmids":["28141794"],"confidence":"High","gaps":["Downstream effectors linking Ser350-phospho-NDRG2 to caspase activation unknown","Relationship to the PTEN/AKT scaffold role unresolved"]},{"year":2019,"claim":"Identified the molecular partner underlying NDRG2's astrocytic glutamate-handling role, linking it to Na+/K+-ATPase function.","evidence":"Co-IP, glutamate uptake assays, blocking peptide, and Ndrg2-knockout mice with in vivo ischemia","pmids":["31250377"],"confidence":"High","gaps":["Direct binding interface with β1 subunit not mapped","How NDRG2 mechanistically enhances pump function unclear"]},{"year":2018,"claim":"Connected NDRG2 to the β-catenin/Skp2 axis, explaining its control of CDK inhibitor stability and differentiation.","evidence":"Ndrg2 knockout mice, ChIP promoter occupancy, and NDRG2 deletion-mutant domain mapping","pmids":["29343851"],"confidence":"High","gaps":["Mechanism by which the N-terminal domain represses β-catenin nuclear translocation unresolved","Direct GSK-3β regulation inferred, not demonstrated"]},{"year":2022,"claim":"Extended the phosphatase-scaffold paradigm to PPM1A/Smad signaling and demonstrated therapeutic disruptability of the interaction.","evidence":"Reciprocal Co-IP, astrocyte-specific Ndrg2 knockout, and a blocking peptide (TAT-QFNP12) in an SAH model","pmids":["36179025"],"confidence":"High","gaps":["Whether NDRG2 inhibits PPM1A catalytic activity or sequesters substrate not distinguished","Generality beyond astrocytes/SAH untested"]},{"year":2020,"claim":"Established NDRG2 as a control point for adherens-junction integrity through ligase-directed Snail turnover.","evidence":"Intestine-specific Ndrg2 knockout, Co-IP of the NDRG2-FBXO11-Snail complex, ubiquitination assay, and colitis models","pmids":["33099085"],"confidence":"High","gaps":["How NDRG2 enhances FBXO11-Snail engagement biochemically unknown","Direct NDRG2-FBXO11 binding interface not mapped"]},{"year":2017,"claim":"Demonstrated the physiological and behavioral consequence of NDRG2-dependent glutamate clearance in vivo.","evidence":"Ndrg2-knockout mice with microdialysis, electrophysiology, and NDRG2 peptide rescue of ADHD-like behavior","pmids":["29058689"],"confidence":"High","gaps":["Molecular mediator of peptide rescue not defined","Link to specific glutamate transporter at this stage indirect"]},{"year":null,"claim":"How NDRG2's distinct activities — phosphatase recruitment, E3-ligase facilitation, and ion-transporter binding — are selected in a given cell type, and whether a unifying biochemical activity underlies them, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of any NDRG2 complex","No defined catalytic activity for NDRG2 itself","Determinants of substrate/partner selection across tissues unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,5,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,14,22]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,27,33]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,14,26,27]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,5,20]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[9,11,23]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[22,13]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[14,28]}],"complexes":[],"partners":["PTEN","PP2A","PPM1A","FBXO11","NIK","ATP1B1","MSP58","PRA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UN36","full_name":"Protein NDRG2","aliases":["N-myc downstream-regulated gene 2 protein","Protein Syld709613"],"length_aa":371,"mass_kda":40.8,"function":"Contributes to the regulation of the Wnt signaling pathway. Down-regulates CTNNB1-mediated transcriptional activation of target genes, such as CCND1, and may thereby act as tumor suppressor. May be involved in dendritic cell and neuron differentiation","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Cell projection, growth cone","url":"https://www.uniprot.org/uniprotkb/Q9UN36/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDRG2","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ATP1A1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NDRG2","total_profiled":1310},"omim":[{"mim_id":"605273","title":"NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3","url":"https://www.omim.org/entry/605273"},{"mim_id":"605272","title":"NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2","url":"https://www.omim.org/entry/605272"},{"mim_id":"601663","title":"ESTROGEN RECEPTOR 2; ESR2","url":"https://www.omim.org/entry/601663"},{"mim_id":"182330","title":"ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1","url":"https://www.omim.org/entry/182330"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Centriolar satellite","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":2060.1},{"tissue":"salivary gland","ntpm":1953.8},{"tissue":"skeletal muscle","ntpm":1707.9},{"tissue":"tongue","ntpm":1485.5}],"url":"https://www.proteinatlas.org/search/NDRG2"},"hgnc":{"alias_symbol":["KIAA1248","SYLD"],"prev_symbol":[]},"alphafold":{"accession":"Q9UN36","domains":[{"cath_id":"3.40.50.1820","chopping":"23-315","consensus_level":"high","plddt":94.402,"start":23,"end":315}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UN36","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UN36-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UN36-F1-predicted_aligned_error_v6.png","plddt_mean":83.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDRG2","jax_strain_url":"https://www.jax.org/strain/search?query=NDRG2"},"sequence":{"accession":"Q9UN36","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UN36.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UN36/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UN36"}},"corpus_meta":[{"pmid":"12845671","id":"PMC_12845671","title":"N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation.","date":"2003","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12845671","citation_count":193,"is_preprint":false},{"pmid":"24569712","id":"PMC_24569712","title":"Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24569712","citation_count":139,"is_preprint":false},{"pmid":"18519680","id":"PMC_18519680","title":"Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18519680","citation_count":118,"is_preprint":false},{"pmid":"12072429","id":"PMC_12072429","title":"Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12072429","citation_count":116,"is_preprint":false},{"pmid":"15207261","id":"PMC_15207261","title":"NDRG2: a novel Alzheimer's disease associated protein.","date":"2004","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15207261","citation_count":110,"is_preprint":false},{"pmid":"18604454","id":"PMC_18604454","title":"NDRG2: a Myc-repressed gene involved in cancer and cell stress.","date":"2008","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/18604454","citation_count":97,"is_preprint":false},{"pmid":"17050536","id":"PMC_17050536","title":"The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17050536","citation_count":82,"is_preprint":false},{"pmid":"14572661","id":"PMC_14572661","title":"Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/14572661","citation_count":82,"is_preprint":false},{"pmid":"18709645","id":"PMC_18709645","title":"Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.","date":"2008","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18709645","citation_count":81,"is_preprint":false},{"pmid":"20206160","id":"PMC_20206160","title":"HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.","date":"2010","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/20206160","citation_count":80,"is_preprint":false},{"pmid":"21676268","id":"PMC_21676268","title":"NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21676268","citation_count":79,"is_preprint":false},{"pmid":"26317652","id":"PMC_26317652","title":"Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26317652","citation_count":79,"is_preprint":false},{"pmid":"15526377","id":"PMC_15526377","title":"NDRG2 expression and mutation in human liver and pancreatic cancers.","date":"2004","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15526377","citation_count":78,"is_preprint":false},{"pmid":"23056173","id":"PMC_23056173","title":"FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23056173","citation_count":77,"is_preprint":false},{"pmid":"36179025","id":"PMC_36179025","title":"Astrocytic NDRG2-PPM1A interaction exacerbates blood-brain barrier disruption after subarachnoid hemorrhage.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36179025","citation_count":76,"is_preprint":false},{"pmid":"25261367","id":"PMC_25261367","title":"The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25261367","citation_count":72,"is_preprint":false},{"pmid":"16520977","id":"PMC_16520977","title":"Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues.","date":"2006","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/16520977","citation_count":70,"is_preprint":false},{"pmid":"19450561","id":"PMC_19450561","title":"Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19450561","citation_count":70,"is_preprint":false},{"pmid":"18160841","id":"PMC_18160841","title":"Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death.","date":"2007","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18160841","citation_count":69,"is_preprint":false},{"pmid":"14985363","id":"PMC_14985363","title":"Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase C theta.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14985363","citation_count":69,"is_preprint":false},{"pmid":"17935612","id":"PMC_17935612","title":"Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.","date":"2007","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17935612","citation_count":69,"is_preprint":false},{"pmid":"18844221","id":"PMC_18844221","title":"NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18844221","citation_count":66,"is_preprint":false},{"pmid":"24816982","id":"PMC_24816982","title":"NDRG2 as a marker protein for brain astrocytes.","date":"2014","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/24816982","citation_count":64,"is_preprint":false},{"pmid":"19237607","id":"PMC_19237607","title":"NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19237607","citation_count":64,"is_preprint":false},{"pmid":"26506239","id":"PMC_26506239","title":"Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26506239","citation_count":62,"is_preprint":false},{"pmid":"16039777","id":"PMC_16039777","title":"Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16039777","citation_count":62,"is_preprint":false},{"pmid":"17888401","id":"PMC_17888401","title":"SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17888401","citation_count":61,"is_preprint":false},{"pmid":"14993068","id":"PMC_14993068","title":"Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes.","date":"2003","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/14993068","citation_count":57,"is_preprint":false},{"pmid":"27113371","id":"PMC_27113371","title":"Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers.","date":"2016","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/27113371","citation_count":57,"is_preprint":false},{"pmid":"29343851","id":"PMC_29343851","title":"NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29343851","citation_count":57,"is_preprint":false},{"pmid":"28141794","id":"PMC_28141794","title":"Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death.","date":"2016","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28141794","citation_count":55,"is_preprint":false},{"pmid":"22110735","id":"PMC_22110735","title":"NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-β1/Smad pathway and altering the MMP2/TIMP2 ratio in rats.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22110735","citation_count":54,"is_preprint":false},{"pmid":"34951340","id":"PMC_34951340","title":"MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34951340","citation_count":51,"is_preprint":false},{"pmid":"19204049","id":"PMC_19204049","title":"NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors.","date":"2009","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19204049","citation_count":51,"is_preprint":false},{"pmid":"28656310","id":"PMC_28656310","title":"KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28656310","citation_count":49,"is_preprint":false},{"pmid":"32207044","id":"PMC_32207044","title":"Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32207044","citation_count":49,"is_preprint":false},{"pmid":"36989575","id":"PMC_36989575","title":"ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36989575","citation_count":47,"is_preprint":false},{"pmid":"29058689","id":"PMC_29058689","title":"Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29058689","citation_count":45,"is_preprint":false},{"pmid":"20045673","id":"PMC_20045673","title":"NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20045673","citation_count":45,"is_preprint":false},{"pmid":"37329577","id":"PMC_37329577","title":"Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction.","date":"2023","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/37329577","citation_count":44,"is_preprint":false},{"pmid":"29445150","id":"PMC_29445150","title":"Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29445150","citation_count":44,"is_preprint":false},{"pmid":"36572898","id":"PMC_36572898","title":"Lactate attenuates astrocytic inflammation by inhibiting ubiquitination and degradation of NDRG2 under oxygen-glucose deprivation conditions.","date":"2022","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/36572898","citation_count":41,"is_preprint":false},{"pmid":"26269411","id":"PMC_26269411","title":"Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26269411","citation_count":41,"is_preprint":false},{"pmid":"33099085","id":"PMC_33099085","title":"NDRG2 regulates adherens junction integrity to restrict colitis and tumourigenesis.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/33099085","citation_count":39,"is_preprint":false},{"pmid":"28209617","id":"PMC_28209617","title":"Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28209617","citation_count":39,"is_preprint":false},{"pmid":"21672576","id":"PMC_21672576","title":"The effect of Ndrg2 expression on astroglial activation.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/21672576","citation_count":39,"is_preprint":false},{"pmid":"30206227","id":"PMC_30206227","title":"The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30206227","citation_count":39,"is_preprint":false},{"pmid":"18520995","id":"PMC_18520995","title":"Immunohistochemical detection of Ndrg2 in the mouse nervous system.","date":"2008","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/18520995","citation_count":39,"is_preprint":false},{"pmid":"27154863","id":"PMC_27154863","title":"N-Myc Downstream-Regulated Gene 2 (Ndrg2) Is Involved in Ischemia-Hypoxia-Induced Astrocyte Apoptosis: a Novel Target for Stroke Therapy.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27154863","citation_count":38,"is_preprint":false},{"pmid":"31250377","id":"PMC_31250377","title":"NDRG2 Protects the Brain from Excitotoxicity by Facilitating Interstitial Glutamate Uptake.","date":"2019","source":"Translational stroke research","url":"https://pubmed.ncbi.nlm.nih.gov/31250377","citation_count":37,"is_preprint":false},{"pmid":"21241684","id":"PMC_21241684","title":"Spatial-temporal expression of NDRG2 in rat brain after focal cerebral ischemia and reperfusion.","date":"2011","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21241684","citation_count":36,"is_preprint":false},{"pmid":"21741166","id":"PMC_21741166","title":"Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21741166","citation_count":36,"is_preprint":false},{"pmid":"25256221","id":"PMC_25256221","title":"NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.","date":"2014","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/25256221","citation_count":35,"is_preprint":false},{"pmid":"18591767","id":"PMC_18591767","title":"Expression of NDRG2 in clear cell renal cell carcinoma.","date":"2008","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/18591767","citation_count":34,"is_preprint":false},{"pmid":"20331630","id":"PMC_20331630","title":"Expression of NDRG2 in esophageal squamous cell carcinoma.","date":"2010","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/20331630","citation_count":34,"is_preprint":false},{"pmid":"33314669","id":"PMC_33314669","title":"LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.","date":"2020","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/33314669","citation_count":32,"is_preprint":false},{"pmid":"17109818","id":"PMC_17109818","title":"The physical and functional interaction of NDRG2 with MSP58 in cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17109818","citation_count":32,"is_preprint":false},{"pmid":"22393400","id":"PMC_22393400","title":"Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22393400","citation_count":32,"is_preprint":false},{"pmid":"23010743","id":"PMC_23010743","title":"DNA methylation of NDRG2 in gastric cancer and its clinical significance.","date":"2012","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23010743","citation_count":31,"is_preprint":false},{"pmid":"17652085","id":"PMC_17652085","title":"(NDRG2) stimulates amiloride-sensitive Na+ currents in Xenopus laevis oocytes and fisher rat thyroid cells.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17652085","citation_count":31,"is_preprint":false},{"pmid":"20673333","id":"PMC_20673333","title":"NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.","date":"2010","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/20673333","citation_count":30,"is_preprint":false},{"pmid":"16142456","id":"PMC_16142456","title":"Expression of androgen receptor and androgen regulation of NDRG2 in the rat renal collecting duct.","date":"2005","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16142456","citation_count":29,"is_preprint":false},{"pmid":"15769300","id":"PMC_15769300","title":"Expression of Ndrg2 in the rat frontal cortex after antidepressant and electroconvulsive treatment.","date":"2005","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15769300","citation_count":29,"is_preprint":false},{"pmid":"23463182","id":"PMC_23463182","title":"NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.","date":"2013","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23463182","citation_count":29,"is_preprint":false},{"pmid":"31834421","id":"PMC_31834421","title":"Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31834421","citation_count":28,"is_preprint":false},{"pmid":"37550295","id":"PMC_37550295","title":"Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healing.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37550295","citation_count":28,"is_preprint":false},{"pmid":"20840522","id":"PMC_20840522","title":"NDRG2 in rat liver regeneration: role in proliferation and apoptosis.","date":"2010","source":"Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society","url":"https://pubmed.ncbi.nlm.nih.gov/20840522","citation_count":27,"is_preprint":false},{"pmid":"34685629","id":"PMC_34685629","title":"N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685629","citation_count":26,"is_preprint":false},{"pmid":"32688030","id":"PMC_32688030","title":"Astrocytic NDRG2 is critical in the maintenance of neuropathic pain.","date":"2020","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32688030","citation_count":26,"is_preprint":false},{"pmid":"21928335","id":"PMC_21928335","title":"Dexamethasone indirectly induces Ndrg2 expression in rat astrocytes.","date":"2011","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/21928335","citation_count":26,"is_preprint":false},{"pmid":"31732915","id":"PMC_31732915","title":"Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.","date":"2019","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/31732915","citation_count":25,"is_preprint":false},{"pmid":"21193923","id":"PMC_21193923","title":"Variation of NDRG2 and c-Myc expression in rat heart during the acute stage of ischemia/reperfusion injury.","date":"2010","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21193923","citation_count":25,"is_preprint":false},{"pmid":"36012631","id":"PMC_36012631","title":"The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36012631","citation_count":24,"is_preprint":false},{"pmid":"20127388","id":"PMC_20127388","title":"NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20127388","citation_count":24,"is_preprint":false},{"pmid":"31903696","id":"PMC_31903696","title":"UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/31903696","citation_count":24,"is_preprint":false},{"pmid":"32329820","id":"PMC_32329820","title":"Association between NDRG2/IL-6/STAT3 signaling pathway and diabetic retinopathy in rats.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32329820","citation_count":23,"is_preprint":false},{"pmid":"28646304","id":"PMC_28646304","title":"NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.","date":"2017","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/28646304","citation_count":23,"is_preprint":false},{"pmid":"24796879","id":"PMC_24796879","title":"Estrogen regulates the expression of Ndrg2 in astrocytes.","date":"2014","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24796879","citation_count":23,"is_preprint":false},{"pmid":"21286383","id":"PMC_21286383","title":"NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production.","date":"2010","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/21286383","citation_count":23,"is_preprint":false},{"pmid":"24847385","id":"PMC_24847385","title":"Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome.","date":"2014","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24847385","citation_count":23,"is_preprint":false},{"pmid":"22819676","id":"PMC_22819676","title":"Ndrg2 regulates vertebral specification in differentiating somites.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22819676","citation_count":23,"is_preprint":false},{"pmid":"19815093","id":"PMC_19815093","title":"NDRG2 induced by oxidized LDL in macrophages antagonizes growth factor productions via selectively inhibiting ERK activation.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19815093","citation_count":21,"is_preprint":false},{"pmid":"34885221","id":"PMC_34885221","title":"NDRG2 Expression in Breast Cancer Cells Downregulates PD-L1 Expression and Restores T Cell Proliferation in Tumor-Coculture.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34885221","citation_count":20,"is_preprint":false},{"pmid":"29530788","id":"PMC_29530788","title":"NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.","date":"2018","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29530788","citation_count":20,"is_preprint":false},{"pmid":"33162818","id":"PMC_33162818","title":"NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2.","date":"2020","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33162818","citation_count":19,"is_preprint":false},{"pmid":"32945444","id":"PMC_32945444","title":"NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32945444","citation_count":19,"is_preprint":false},{"pmid":"23068607","id":"PMC_23068607","title":"NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/β-catenin signaling.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/23068607","citation_count":19,"is_preprint":false},{"pmid":"31843625","id":"PMC_31843625","title":"Suppression of NDRG2 alleviates brain injury after intracerebral hemorrhage through mitigating astrocyte-drived glutamate neurotoxicity via NF-κB/GLT1 signaling.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31843625","citation_count":19,"is_preprint":false},{"pmid":"30348117","id":"PMC_30348117","title":"NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30348117","citation_count":18,"is_preprint":false},{"pmid":"26208882","id":"PMC_26208882","title":"The loss of NDRG2 expression improves depressive behavior through increased phosphorylation of GSK3β.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/26208882","citation_count":18,"is_preprint":false},{"pmid":"26976975","id":"PMC_26976975","title":"NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.","date":"2016","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26976975","citation_count":18,"is_preprint":false},{"pmid":"26631961","id":"PMC_26631961","title":"NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26631961","citation_count":18,"is_preprint":false},{"pmid":"21338239","id":"PMC_21338239","title":"NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.","date":"2010","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/21338239","citation_count":17,"is_preprint":false},{"pmid":"29285747","id":"PMC_29285747","title":"Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition.","date":"2017","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/29285747","citation_count":17,"is_preprint":false},{"pmid":"22692967","id":"PMC_22692967","title":"Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.","date":"2012","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22692967","citation_count":17,"is_preprint":false},{"pmid":"30556863","id":"PMC_30556863","title":"Hypoxia promotes migration and invasion of gastric cancer cells by activating HIF-1α and inhibiting NDRG2 associated signaling pathway.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30556863","citation_count":17,"is_preprint":false},{"pmid":"26250123","id":"PMC_26250123","title":"Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.","date":"2016","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26250123","citation_count":16,"is_preprint":false},{"pmid":"27007654","id":"PMC_27007654","title":"Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.","date":"2016","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/27007654","citation_count":16,"is_preprint":false},{"pmid":"34373985","id":"PMC_34373985","title":"Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.","date":"2021","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34373985","citation_count":16,"is_preprint":false},{"pmid":"36652790","id":"PMC_36652790","title":"Inhibition of PI3K/Akt/mTOR signaling by NDRG2 contributes to neuronal apoptosis and autophagy in ischemic stroke.","date":"2023","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/36652790","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53675,"output_tokens":9165,"usd":0.14925,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19076,"output_tokens":3624,"usd":0.09299,"stage2_stop_reason":"end_turn"},"total_usd":0.24224,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"NDRG2 is a PTEN-binding protein that recruits protein phosphatase 2A (PP2A) to PTEN, thereby promoting dephosphorylation of PTEN at the Ser380/Thr382/Thr383 cluster within the C-terminal tail; loss of NDRG2 leads to enhanced PTEN phosphorylation at this cluster, inactivating PTEN and constitutively activating the PI3K-AKT pathway.\",\n      \"method\": \"Co-immunoprecipitation, binding assays, phosphorylation analysis, cell-based overexpression/knockdown, Ndrg2-knockout mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP establishing the NDRG2-PTEN-PP2A complex, multiple orthogonal methods (binding, phosphorylation assays, KO mice), replicated in subsequent papers (PMID:26269411)\",\n      \"pmids\": [\"24569712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG2 also recruits PP2A to NF-κB-inducing kinase (NIK), promoting NIK dephosphorylation and thereby suppressing the non-canonical NF-κB pathway, in addition to its role in suppressing PI3K/AKT signaling via PTEN dephosphorylation.\",\n      \"method\": \"Forced expression of NDRG2 in ATL cells, immunoprecipitation, phosphorylation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, Co-IP and phosphorylation data, single study without independent replication\",\n      \"pmids\": [\"26269411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Akt directly phosphorylates NDRG2 at Thr-348 in response to insulin, while PKCθ phosphorylates NDRG2 at Ser-332; PKCθ overexpression reduces insulin-stimulated Thr-348 phosphorylation without reducing Akt activation, suggesting cross-talk at the substrate level.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, [32P]-orthophosphate labeling, phospho-Akt-substrate antibody, co-overexpression in C2C12 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase reconstitution with mutagenesis confirming specific phosphorylation sites, supported by cell-based validation with multiple methods\",\n      \"pmids\": [\"14985363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DAPK1 directly interacts with NDRG2 and phosphorylates it at Ser350 in vitro and in vivo; DAPK1-mediated phosphorylation of NDRG2-Ser350 promotes caspase-dependent neuronal cell death, and DAPK1 inhibition abolishes NDRG2-Ser350 phosphorylation and reduces neuronal death in primary neurons and mouse brain.\",\n      \"method\": \"Phospho-peptide library screening, in vitro kinase assay, Co-IP, cell-based overexpression and shRNA knockdown, primary neuron experiments, Tg2576 mouse model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — substrate identified by peptide library screen, confirmed by in vitro phosphorylation with mutagenesis, validated in multiple cell models and in vivo\",\n      \"pmids\": [\"28141794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"c-Myc represses NDRG2 transcription through interaction with the NDRG2 core promoter via Miz-1 and recruitment of histone deacetylases; Miz-1 association is required for c-Myc-mediated NDRG2 repression.\",\n      \"method\": \"Reporter assay, chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), ectopic c-Myc expression, Miz-1 co-expression/knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and in vitro/in vivo promoter binding with mutagenesis, multiple orthogonal methods, mechanistic dissection of Miz-1 requirement\",\n      \"pmids\": [\"17050536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cytoplasmic NDRG2 in astrocytes binds to the protein phosphatase PPM1A and restricts dephosphorylation of Smad2/3; after subarachnoid hemorrhage, this NDRG2-PPM1A interaction reduces Smad2/3 dephosphorylation, sustaining MMP-9 transcription and blood-brain barrier disruption. A blocking peptide (TAT-QFNP12) that disrupts the NDRG2-PPM1A interaction attenuates MMP-9 production and BBB damage.\",\n      \"method\": \"Co-immunoprecipitation, Ndrg2 astrocyte-specific knockout mice, phosphorylation analysis of Smad2/3, peptide competition, in vivo SAH model\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, cell-specific KO model, functional peptide rescue, mechanistic pathway validated with multiple orthogonal approaches\",\n      \"pmids\": [\"36179025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NDRG2 stimulates amiloride-sensitive ENaC currents by increasing ENaC surface expression in Xenopus oocytes and Fisher rat thyroid cells; siRNA knockdown of NDRG2 reduces ENaC-mediated short-circuit current, and the stimulatory effect is at least partially additive to Sgk1.\",\n      \"method\": \"Xenopus oocyte electrophysiology, chemiluminescence surface expression assay, siRNA knockdown in Fisher rat thyroid cells, short-circuit current measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional electrophysiology with surface expression quantification, confirmed in two heterologous cell systems with loss-of-function validation\",\n      \"pmids\": [\"17652085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NDRG2 physically interacts with MSP58 (58-kDa microspherule protein) via the forkhead-associated domain of MSP58; the two proteins co-localize in the nucleus during cell stress, and modulation of NDRG2 levels influences cell cycle progression together with MSP58.\",\n      \"method\": \"Yeast two-hybrid screening, GST pull-down, co-immunoprecipitation, confocal co-localization\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple binding confirmation methods (yeast two-hybrid, pull-down, Co-IP, co-localization), single lab, functional consequence partially characterized\",\n      \"pmids\": [\"17109818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NDRG2 interacts with prenylated Rab acceptor-1 (PRA1) as identified by yeast two-hybrid screening; the interaction was confirmed by GST pull-down and immunoprecipitation. NDRG2 and PRA1 co-localize in HCT116 cells and synergistically downregulate TCF promoter activity and GSK3β phosphorylation.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, confocal microscopy, TCF/LEF luciferase reporter assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — binding confirmed by three orthogonal methods plus functional reporter assay, single lab\",\n      \"pmids\": [\"23068607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NDRG2 expression in colon carcinoma cells reduces c-Jun phosphorylation at Ser63, attenuating AP-1 transcriptional activity and downstream cyclin D1 expression, resulting in G1/S cell cycle arrest; NDRG2 mutants lacking C-terminal phosphorylation sites lose this activity.\",\n      \"method\": \"Stable cell lines with wild-type and deletion/point mutant NDRG2, Western blotting, luciferase reporter assay, flow cytometry, siRNA rescue\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis identifying C-terminal phosphorylation sites as required, multiple assays, single lab\",\n      \"pmids\": [\"18844221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NDRG2 expression reduces TCF/LEF transcriptional activity in colon cancer cells and modulates β-catenin stability through regulation of GSK-3β activity; NDRG2 mutants lacking C-terminal phosphorylation sites lose this regulatory activity.\",\n      \"method\": \"TOPflash TCF/LEF luciferase reporter assay, Western blotting for β-catenin and GSK-3β, site-directed mutagenesis, stable cell transfection\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter and mutagenesis in single lab, mechanistically tied to GSK-3β activity modulation\",\n      \"pmids\": [\"19237607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NDRG2 induction of colorectal cancer cell differentiation is dependent on repression of E3 ligase Skp2, which stabilizes the CDK inhibitors p21 and p27; NDRG2 suppresses Skp2 by reducing β-catenin nuclear translocation and decreasing β-catenin/TCF occupancy on the Skp2 promoter, potentially through dephosphorylation of GSK-3β. The NH2-terminal domain of NDRG2 is required for Skp2 suppression.\",\n      \"method\": \"Ndrg2 knockout mice, shRNA knockdown, Western blotting, ChIP, promoter occupancy assay, NDRG2 deletion mutants, alkaline phosphatase (AKP) activity assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mapping combined with KO mouse model and ChIP confirming promoter occupancy, multiple orthogonal methods in single lab plus in vivo validation\",\n      \"pmids\": [\"29343851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression via suppression of β-catenin nuclear translocation, which reduces transcriptional activation of the C-MYC gene; this consequently decreases expression of GLUT1, HK2, PKM2, LDHA, ASCT2, and GLS1.\",\n      \"method\": \"Metabolite measurement (glucose/lactate/glutamine/glutamate), Western blotting, β-catenin knockdown, c-Myc knockdown, NDRG2 overexpression in colorectal cancer cells\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional metabolic assays combined with mechanistic pathway dissection, single lab with multiple methods\",\n      \"pmids\": [\"26317652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG2 ablation induces glutamine dependence via Akt-dependent inhibition of Fbw7-mediated c-Myc degradation, which increases c-Myc-driven ASCT2 (glutamine transporter) transcription; NDRG2 promotes Fbw7-dependent c-Myc degradation by inhibiting Akt, and ASCT2 restoration reverses NDRG2's inhibitory effect on EMT and metastasis.\",\n      \"method\": \"Immunoprecipitation, protein half-life assay, luciferase reporter, ChIP, mRNA-seq, NDRG2-knockout MEF cells, functional invasion/migration assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic chain (NDRG2→Akt→Fbw7→c-Myc→ASCT2) validated by IP, ChIP, half-life, and functional rescue in single lab\",\n      \"pmids\": [\"33162818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDRG2 promotes astroglial glutamate uptake by interacting with and promoting the function of Na+/K+-ATPase β1 subunit; NDRG2 knockout reduces EAAT-mediated glutamate uptake and increases interstitial glutamate in mouse brain, leading to greater neuronal death upon glutamate challenge.\",\n      \"method\": \"Ndrg2-knockout mice, Co-IP demonstrating NDRG2-Na+/K+-ATPase β1 interaction, glutamate uptake assay in astrocytes, Na+/K+-ATPase β1 blocking peptide, neuronal death assay, in vivo ischemia model\",\n      \"journal\": \"Translational stroke research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse model combined with Co-IP establishing binding partner and functional consequence, peptide competition confirming mechanism, in vitro and in vivo validation\",\n      \"pmids\": [\"31250377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KLF4 transcriptionally activates NDRG2 by directly binding to the NDRG2 promoter; KLF4-dependent inhibition of colorectal cancer cell proliferation is dependent on NDRG2 expression, as NDRG2 knockdown abrogates the anti-proliferative effect of KLF4.\",\n      \"method\": \"Chromatin immunoprecipitation, luciferase reporter assay, MTT assay, EdU staining, colony formation, xenograft mouse model, siRNA knockdown\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter confirming direct promoter binding, epistasis validated by rescue experiment, single lab\",\n      \"pmids\": [\"28656310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Farnesoid X receptor (FXR) directly controls NDRG2 transcription through IR1-type response elements identified in the first introns of the human, mouse and rat NDRG2 genes, as supported by gene reporter assays and chromatin immunoprecipitation.\",\n      \"method\": \"Gene reporter assay, chromatin immunoprecipitation, FXR ectopic expression, FXR knockout mice, non-steroidal FXR agonist treatment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with FXR binding element identified, validated in FXR KO mice and agonist-treated cells, single lab\",\n      \"pmids\": [\"23056173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NDRG2 overexpression in liver cancer cells specifically induces active BMP-4 expression; neutralization of BMP-4 in NDRG2-expressing cells restores MMP-9 mRNA expression and migration capacity, demonstrating that NDRG2 suppresses MMP-9 activity and migration through BMP-4 induction.\",\n      \"method\": \"NDRG2 stable overexpression, BMP-4 neutralizing antibody, recombinant BMP-4 treatment, gelatin zymography for MMP-9 activity, migration and invasion assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by BMP-4 neutralization rescue experiment, multiple functional readouts, single lab\",\n      \"pmids\": [\"19450561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NDRG2 expression in breast cancer cells increases SOCS1 mRNA and protein expression in a p38 MAPK-dependent manner; this SOCS1 induction inhibits JAK2/STAT3 activation, as p38 MAPK inhibition blocks SOCS1 induction by NDRG2 and rescues STAT3 phosphorylation.\",\n      \"method\": \"Western blotting for phospho-Akt, p38, JNK, JAK2, STAT3, RT-PCR for SOCS1, p38 inhibitor treatment, stable NDRG2 overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis confirmed by kinase inhibitor rescue, multiple phosphorylation readouts, single lab\",\n      \"pmids\": [\"17888401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NDRG2 suppresses TGF-β1/Smad3 signaling in hepatic stellate cells by reducing Smad3 transcription and phosphorylation, and increases the MMP2/TIMP2 ratio; adenovirus-mediated NDRG2 overexpression in fibrotic rat livers reduces ECM deposition and improves liver function.\",\n      \"method\": \"NDRG2 overexpression and knockdown in HSCs, Western blotting for phospho-Smad3, gelatin zymography, adenovirus delivery in dimethylnitrosamine-induced rat fibrosis model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro signaling combined with in vivo adenoviral overexpression in fibrosis model, single lab\",\n      \"pmids\": [\"22110735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG2 directly interacts with NF-κB and inhibits nuclear import and DNA binding activity of the NF-κB p65 subunit in astrocytes after OxyHb treatment, reducing glutamate transporter 1 (GLT1) transcription and impairing glutamate uptake in the context of intracerebral hemorrhage.\",\n      \"method\": \"Ndrg2-knockout mice, Co-IP demonstrating NDRG2-NF-κB interaction, NF-κB nuclear translocation assay, GLT1 promoter analysis, primary astrocyte culture, ICH mouse model\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing direct NDRG2-NF-κB interaction, functional consequence on GLT1 and glutamate uptake validated in KO mice, single lab\",\n      \"pmids\": [\"31843625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In NDRG2-deficient astrocytes, NDRG2 loss increases NF-κB phosphorylation, activating complement C3 transcription; NDRG2 overexpression inhibits complement C3 via NF-κB suppression, reducing synaptic injury in diabetic mice. C3aR blockade rescued dendritic spine loss consistent with NDRG2/NF-κB/C3/C3aR as a signaling axis.\",\n      \"method\": \"Ndrg2 knockout and overexpression in vivo, Western blotting, immunofluorescence, electrophysiology, Golgi staining, RNA-seq and proteome sequencing with WGCNA\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-omics combined with in vivo genetic manipulation and pharmacological C3aR blockade, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"37329577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG2 enhances FBXO11-mediated ubiquitination and degradation of Snail (a repressor of E-cadherin), thereby maintaining E-cadherin expression and adherens junction integrity in intestinal epithelial cells; intestine-specific Ndrg2 deletion leads to Snail accumulation, E-cadherin loss, and increased intestinal permeability.\",\n      \"method\": \"Intestine-specific Ndrg2 knockout mice, Co-IP for NDRG2-FBXO11-Snail complex, ubiquitination assay, Western blotting, barrier permeability assay, DSS/TNBS colitis models\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP establishing ternary complex, ubiquitination assay, tissue-specific KO with functional phenotype, multiple disease models\",\n      \"pmids\": [\"33099085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NDRG2 overexpression in rat liver cells induces cell cycle arrest and apoptosis associated with induction of p53 and p21, increased Bax/Bcl-2 ratio, and inhibition of cyclin E-Cdk2; conversely, p53 upregulates NDRG2 expression in A-498 cells, suggesting a positive feedback loop.\",\n      \"method\": \"Adenoviral NDRG2 overexpression in BRL cells, flow cytometry, Western blotting for cell cycle regulators and apoptosis markers\",\n      \"journal\": \"Wound repair and regeneration\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, KO/overexpression with Western blot readouts but no direct binding or epistasis confirmation for p53-NDRG2 relationship\",\n      \"pmids\": [\"20840522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG2 acts downstream of PI3K/Akt signaling in cardiomyocytes; insulin increases Akt-dependent NDRG2 phosphorylation, and shRNA knockdown of NDRG2 renders cardiomyocytes more susceptible to ischemia/reperfusion injury and blunts insulin's anti-apoptotic cardioprotective effect.\",\n      \"method\": \"Rat I/R model, lentiviral shRNA NDRG2 knockdown in cardiomyocytes and in vivo, Western blotting for phospho-Akt and phospho-NDRG2, wortmannin/Akt inhibitor pretreatment, infarct size measurement\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in vitro and in vivo with PI3K/Akt inhibitor epistasis, single lab\",\n      \"pmids\": [\"23463182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NDRG2 is highly expressed in pancreatic beta cells and acts as an Akt substrate; in beta cells under lipotoxic stress, Akt-mediated NDRG2 phosphorylation is reduced; NDRG2 knockdown attenuates constitutively active Akt-mediated protection against fatty acid-induced apoptosis, placing NDRG2 downstream of Akt in beta cell survival signaling.\",\n      \"method\": \"Stable overexpression of constitutively active Akt, NDRG2 knockdown in beta-TC3 cells, Western blotting, apoptosis assay\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (active Akt + NDRG2 knockdown rescue) in beta cell model, functional apoptosis readout, single lab\",\n      \"pmids\": [\"20127388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NDRG2 protein (both S and L isoforms) localizes specifically to cell surface membranes and growth cones in NGF-differentiated PC12 cells, and overexpression of either isoform promotes neurite elongation.\",\n      \"method\": \"V5-tagged NDRG2 transfection, immunofluorescence/confocal microscopy, real-time qPCR for expression, morphological measurement of neurite length\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by immunofluorescence tied to functional phenotype (neurite elongation), replicated for both isoforms, single lab\",\n      \"pmids\": [\"16039777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In cultured astrocytes, Ndrg2 gene silencing enhances cell proliferation (BrdU/PCNA incorporation) and reduces F-actin levels and process length, while Ndrg2 overexpression has opposite effects; fractionation and immunocytochemistry show Ndrg2 in cytosol and cell surface membrane fractions.\",\n      \"method\": \"Adenovirus-mediated Ndrg2 overexpression and siRNA knockdown in astrocytes, BrdU incorporation, PCNA staining, F-actin quantification, subcellular fractionation, MPTP mouse model\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — bidirectional manipulation (overexpression and knockdown) with consistent proliferation and morphology readouts, subcellular fractionation, single lab\",\n      \"pmids\": [\"21672576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDRG2 deficiency in Ndrg2-knockout mice leads to markedly increased interstitial glutamate and reduced astroglial glutamate clearance; an NDRG2 peptide rescues astroglial glutamate clearance, reduces excitatory transmission, and rescues ADHD-like hyperactivity in Ndrg2-/- mice.\",\n      \"method\": \"Ndrg2-knockout mice, microdialysis for interstitial glutamate, electrophysiology for excitatory transmission, astrocyte glutamate uptake assay, NDRG2 peptide treatment, behavioral testing\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse model with multiple functional readouts (glutamate levels, electrophysiology, behavior), peptide rescue confirming mechanism, published in high-impact journal with rigorous controls\",\n      \"pmids\": [\"29058689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NDRG2 overexpression in breast cancer cells inhibits PD-L1 expression through NF-κB signaling; knockdown of NDRG2 enhances PD-L1 expression and leads to suppression of T cell proliferation in co-culture, while NDRG2 overexpression in 4T1 mouse cells blocks tumor cell-mediated suppression of T cell proliferation.\",\n      \"method\": \"NDRG2 overexpression and knockdown, Western blotting, RT-qPCR, T cell proliferation co-culture assay, NF-κB pathway analysis\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation with functional T cell co-culture readout, NF-κB mechanistic link, single lab\",\n      \"pmids\": [\"34885221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG2 suppression in astrocytes attenuates ischemia-induced necroptosis by suppressing RIPK1 expression; Ndrg2-/- mice exhibit accelerated necroptosis after cerebral artery occlusion, and pharmacological inhibition of necroptosis by necrostatin-1 provides neuroprotection after NDRG2 knockdown.\",\n      \"method\": \"Ndrg2 conditional knockout mice, Western blotting for RIPK1 and necroptosis markers, necrostatin-1 treatment, permanent MCAO model\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with pharmacological epistasis (necrostatin-1 rescue), single lab\",\n      \"pmids\": [\"32945444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Lactate stabilizes NDRG2 in astrocytes under oxygen-glucose deprivation by inhibiting its ubiquitination; NDRG2 knockdown in astrocytes increases TNFα expression and secretion via c-Jun phosphorylation, indicating that NDRG2 suppresses neuroinflammation by restraining the c-Jun/TNFα axis.\",\n      \"method\": \"Ubiquitination assay, Western blotting, siRNA knockdown, exogenous lactate treatment, RNA-seq transcriptomics, primary astrocyte culture, MCAO rat model\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay directly showing lactate-mediated stabilization, mechanistic link to c-Jun/TNFα, single lab\",\n      \"pmids\": [\"36572898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ndrg2 loss in mice results in vertebral homeotic transformations; at the molecular level, this is accompanied by altered Hoxc8-11 gene transcripts and elevated BMP/Smad signaling in differentiating somites, identifying Ndrg2 as a regulator of vertebral specification after somite segmentation.\",\n      \"method\": \"Ndrg2-knockout mice, conditional knockout in osteoblasts/chondrocytes, Ndrg2 overexpression in osteoblasts/chondrocytes, in situ hybridization for Hox genes, immunostaining for phospho-Smad\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic models (global KO, cell-type-specific KO and OE) with molecular readouts, single lab\",\n      \"pmids\": [\"22819676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NDRG2 is predominantly localized to the cytosol of protoplasmic and fibrous astrocytes in mammalian brain, including fine distal processes but not Müller glia; NDRG2 is reduced in reactive astrocytes at a cortical lesion, suggesting its expression is specific to mature, non-reactive astrocytes.\",\n      \"method\": \"Immunohistochemistry and confocal immunofluorescence with astrocyte markers (GFAP, S100β, aquaporin-4, nestin, NG2) in multiple species (mouse, rat, tree shrew, marmoset, human), cortical lesion model\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — extensive multi-species immunolocalization with co-marker analysis, direct functional implication (reduction in reactive astrocytes), multiple orthogonal markers\",\n      \"pmids\": [\"24816982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NDRG2 regulates CD24 expression in hepatocellular carcinoma cells; NDRG2 upregulation decreases CD24 expression and reduces cell adhesion, migration and invasion, while NDRG2 downregulation enhances CD24 expression and increases these behaviors.\",\n      \"method\": \"Adenovirus-mediated NDRG2 overexpression and siRNA knockdown in HCC cells, Western blotting, adhesion/migration/invasion assays, IHC correlation in 50 patient specimens\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, functional assays linking NDRG2 to CD24 without direct binding confirmation; mechanism of CD24 regulation unspecified\",\n      \"pmids\": [\"21676268\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDRG2 functions primarily as an adaptor/scaffold protein: it recruits PP2A phosphatase to PTEN (dephosphorylating and activating PTEN to suppress PI3K/AKT) and to NIK (suppressing non-canonical NF-κB), interacts with Na+/K+-ATPase β1 in astrocytes to promote EAAT-mediated glutamate uptake, binds PPM1A to regulate Smad2/3 dephosphorylation and MMP-9 transcription, enhances FBXO11-mediated Snail ubiquitination to maintain E-cadherin/adherens junctions, and is itself phosphorylated by Akt (at Thr-348) and PKCθ (at Ser-332) downstream of insulin signaling, and by DAPK1 (at Ser-350) to promote neuronal apoptosis; transcriptionally, c-Myc represses NDRG2 via Miz-1, FXR and KLF4 activate it, and aldosterone induces it as an early mineralocorticoid-specific response gene that enhances ENaC surface expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NDRG2 is a cytosolic adaptor/scaffold protein that suppresses proliferative and inflammatory signaling by recruiting protein phosphatases to specific substrates and by controlling protein stability through dedicated E3 ligases [#0, #5, #22]. Its best-defined activity is recruiting PP2A to PTEN, driving dephosphorylation of the PTEN C-terminal Ser380/Thr382/Thr383 cluster to activate PTEN and restrain PI3K-AKT signaling; loss of NDRG2 hyperphosphorylates PTEN and constitutively activates AKT [#0]. The same scaffolding logic extends to PP2A recruitment to NIK to dampen non-canonical NF-\\u03baB [#1], and to PPM1A engagement, where cytoplasmic NDRG2 restricts Smad2/3 dephosphorylation to sustain MMP-9 transcription [#5]. NDRG2 also stabilizes adherens junctions by enhancing FBXO11-mediated ubiquitination and degradation of the E-cadherin repressor Snail [#22]. Across colorectal cancer models NDRG2 converges on the \\u03b2-catenin/c-Myc axis, suppressing \\u03b2-catenin nuclear translocation and TCF/LEF activity to repress Skp2, c-Myc, and downstream glycolytic and glutaminolytic programs, thereby imposing G1/S arrest and a differentiated phenotype [#11, #12, #13]. In the brain, NDRG2 is an astrocyte-enriched protein that interacts with the Na+/K+-ATPase \\u03b21 subunit to promote EAAT-mediated glutamate uptake, limiting excitotoxicity and behavioral hyperactivity [#14, #28]. NDRG2 is itself a phosphorylation hub: AKT phosphorylates it at Thr-348 and PKC\\u03b8 at Ser-332 downstream of insulin [#2], while DAPK1 phosphorylates Ser-350 to promote caspase-dependent neuronal death [#3]. Its expression is repressed by c-Myc via Miz-1 and activated by KLF4 and FXR [#4, #15, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that NDRG2 is a direct kinase substrate integrating insulin signaling, defining the regulatory phosphorylation sites that gate its activity.\",\n      \"evidence\": \"In vitro kinase assays with site-directed mutagenesis and [32P] labeling in C2C12 cells identifying Akt-Thr348 and PKC\\u03b8-Ser332\",\n      \"pmids\": [\"14985363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of each phosphosite on NDRG2 scaffold activity not resolved\", \"Did not address downstream effectors of phosphorylated NDRG2\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed how NDRG2 expression itself is controlled, identifying c-Myc/Miz-1 as a transcriptional repressor circuit.\",\n      \"evidence\": \"Reporter assays, ChIP, and EMSA with ectopic c-Myc and Miz-1 manipulation\",\n      \"pmids\": [\"17050536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reciprocal regulation (NDRG2 repressing c-Myc) not yet connected\", \"HDAC identity at the promoter unspecified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the core molecular mechanism of NDRG2 as a phosphatase-recruiting scaffold, explaining its tumor-suppressive link to PI3K-AKT.\",\n      \"evidence\": \"Reciprocal Co-IP, phosphorylation analysis of the PTEN C-terminal cluster, and Ndrg2-knockout mice\",\n      \"pmids\": [\"24569712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the NDRG2-PTEN-PP2A ternary complex unknown\", \"Which PP2A holoenzyme is recruited not specified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Generalized the scaffold model by showing NDRG2 also recruits PP2A to NIK to suppress non-canonical NF-\\u03baB.\",\n      \"evidence\": \"Forced NDRG2 expression in ATL cells with immunoprecipitation and phosphorylation assays\",\n      \"pmids\": [\"26269411\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study without independent replication\", \"Direct NDRG2-NIK binding versus PP2A bridging not distinguished\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed a death-promoting arm of NDRG2 regulation, showing DAPK1 phosphorylation converts NDRG2 into a pro-apoptotic neuronal factor.\",\n      \"evidence\": \"Phospho-peptide library screen, in vitro kinase assay with mutagenesis, and validation in primary neurons and Tg2576 mice\",\n      \"pmids\": [\"28141794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors linking Ser350-phospho-NDRG2 to caspase activation unknown\", \"Relationship to the PTEN/AKT scaffold role unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified the molecular partner underlying NDRG2's astrocytic glutamate-handling role, linking it to Na+/K+-ATPase function.\",\n      \"evidence\": \"Co-IP, glutamate uptake assays, blocking peptide, and Ndrg2-knockout mice with in vivo ischemia\",\n      \"pmids\": [\"31250377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface with \\u03b21 subunit not mapped\", \"How NDRG2 mechanistically enhances pump function unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected NDRG2 to the \\u03b2-catenin/Skp2 axis, explaining its control of CDK inhibitor stability and differentiation.\",\n      \"evidence\": \"Ndrg2 knockout mice, ChIP promoter occupancy, and NDRG2 deletion-mutant domain mapping\",\n      \"pmids\": [\"29343851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which the N-terminal domain represses \\u03b2-catenin nuclear translocation unresolved\", \"Direct GSK-3\\u03b2 regulation inferred, not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended the phosphatase-scaffold paradigm to PPM1A/Smad signaling and demonstrated therapeutic disruptability of the interaction.\",\n      \"evidence\": \"Reciprocal Co-IP, astrocyte-specific Ndrg2 knockout, and a blocking peptide (TAT-QFNP12) in an SAH model\",\n      \"pmids\": [\"36179025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NDRG2 inhibits PPM1A catalytic activity or sequesters substrate not distinguished\", \"Generality beyond astrocytes/SAH untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established NDRG2 as a control point for adherens-junction integrity through ligase-directed Snail turnover.\",\n      \"evidence\": \"Intestine-specific Ndrg2 knockout, Co-IP of the NDRG2-FBXO11-Snail complex, ubiquitination assay, and colitis models\",\n      \"pmids\": [\"33099085\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NDRG2 enhances FBXO11-Snail engagement biochemically unknown\", \"Direct NDRG2-FBXO11 binding interface not mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated the physiological and behavioral consequence of NDRG2-dependent glutamate clearance in vivo.\",\n      \"evidence\": \"Ndrg2-knockout mice with microdialysis, electrophysiology, and NDRG2 peptide rescue of ADHD-like behavior\",\n      \"pmids\": [\"29058689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mediator of peptide rescue not defined\", \"Link to specific glutamate transporter at this stage indirect\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NDRG2's distinct activities — phosphatase recruitment, E3-ligase facilitation, and ion-transporter binding — are selected in a given cell type, and whether a unifying biochemical activity underlies them, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of any NDRG2 complex\", \"No defined catalytic activity for NDRG2 itself\", \"Determinants of substrate/partner selection across tissues unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 5, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 14, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 27, 33]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 14, 26, 27]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 5, 20]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [9, 11, 23]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [22, 13]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [14, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PTEN\", \"PP2A\", \"PPM1A\", \"FBXO11\", \"NIK\", \"ATP1B1\", \"MSP58\", \"PRA1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}